osaühing MIECYS-PHARMRegistered
Key figures
1 986 418 €−3,0%
Revenue 2025
−5,4%
Average annual change 2019–2025
Ratios
20255,3%
Profit margin
5,2%
EBITDA margin
85,3%
Equity ratio
6,8×
Current ratio
10,5%
Return on equity
2482 €
Average gross salary
Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 644 469 € | 5 | 19 971 € |
| Q1 2026 | 897 031 € | 3 | 25 110 € |
| Q4 2025 | 1 007 590 € | 3 | 19 985 € |
| Q3 2025 | 678 769 € | 3 | 18 388 € |
| Q2 2025 | 675 904 € | 3 | 18 753 € |
| Q1 2025 | 894 211 € | 3 | 21 002 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
20240 €
20230 €
20220 €
2021127 551 €
20201350 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 1 518 203 | 1 043 191 | 871 558 | 970 106 | 1 224 771 | 1 048 628 | 1 169 143 |
| Total non-current assets | — | — | 1535 | 1132 | 0 | — | — |
| Total assets | 1 518 203 | 1 043 191 | 873 093 | 971 238 | 1 224 771 | 1 048 628 | 1 169 143 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 711 777 | 233 672 | 226 078 | 277 075 | 400 486 | 156 443 | 172 300 |
| Non-current liabilities | — | — | — | — | — | — | — |
| Total liabilities | 711 777 | 233 672 | 226 078 | 277 075 | 400 486 | 156 443 | 172 300 |
| Share capital | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 | 2550 |
| Retained earnings of previous periods | 750 558 | 802 270 | 679 162 | 644 209 | 691 357 | 821 479 | 889 379 |
| Profit for the year | 53 062 | 4443 | −34 953 | 47 148 | 130 122 | 67 900 | 104 658 |
| Reserves and other equity | 256 | 256 | 256 | 256 | 256 | 256 | 256 |
| Total equity | 806 426 | 809 519 | 647 015 | 694 163 | 824 285 | 892 185 | 996 843 |
| Income statement | |||||||
| Sales revenue | 2 775 460 | 2 268 551 | 1 563 317 | 1 742 641 | 2 054 671 | 2 048 523 | 1 986 418 |
| Operating profit | 63 858 | 4427 | −34 973 | 47 130 | 127 252 | 64 567 | 103 653 |
| EBITDA | 63 858 | — | −34 837 | 47 533 | 128 384 | 64 567 | 103 653 |
| Profit before income tax | 63 876 | 4443 | −34 953 | 47 148 | 130 122 | 67 900 | 104 658 |
| Profit for the reporting year | 53 062 | 4443 | −34 953 | 47 148 | 130 122 | 67 900 | 104 658 |
| Labour costs | 224 132 | 185 223 | 179 016 | 221 785 | 163 240 | 171 423 | 195 123 |
| Depreciation of non-current assets | 0 | — | 136 | 403 | 1132 | 0 | 0 |
| Other indicators | |||||||
| Employees | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Calculated dividend | — | 1350 | 127 551 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Ravimite ja muude apteegikaupade hulgimüük
Same address